The president of Turkey’s social security institution, the SGK, discusses the evolution of healthcare spending over the past three years, and the underpinning principles guiding their…
In Conversation
The chairman and general manager of Bottu discuss their flagship product, Doliprane, the potential for export to the rest of Africa, and partnerships with European labs.
The CEO of one of Morocco's largest pharma companies discusses investment in production capacity, and the potential to export products to French and English-speaking Africa.
The director general of Cooper Pharma explains how the company has become the leading Moroccan player, why Morocco´s relationship with Africa is one of cooperation not…
The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.
The director general of Afric-Phar explains why it is difficult for the local players to compete with multinationals, how the Moroccan market is being reformed for…
The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the…
The president and director general of Sanofi Morocco talks about the impact of public/private partnerships for the development of the Moroccan health sector, explains why 2013…
Morocco has become GSK's regional hub thanks to the quality of human capital in the country, explains the company's area director, president and general manager for North Africa,…
Ralf Halbach discusses the impact of low health coverage in Morocco on Roche's strategy, and the fact that the company chose Morocco as the country to…
The country president and general director of Novartis Morocco discusses the impact of the price cuts on the pharma market, the need to change the health…
The country manager of Pfizer Morocco talks about the likelihood of Morocco becoming an African hub and why Pfizer is at the perfect size to play…
